{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:10:27Z","timestamp":1783109427147,"version":"3.54.6"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515010028"],"award-info":[{"award-number":["2022A1515010028"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"DOI":"10.1186\/s13568-025-01931-4","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:00:04Z","timestamp":1755522004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic potential of recombinant IL-22BP in psoriasis: suppression of IL-22\/STAT3 signaling in mice"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiuze","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binqian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"5","key":"1931_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41385-019-0188-7","volume":"12","author":"RN Abood","year":"2019","unstructured":"Abood RN, McHugh KJ, Rich HE, Ortiz MA, Tobin JM, Ramanan K, Robinson KM, Bomberger JM, Kolls JK, Manni ML, Pociask DA, Alcorn JF (2019) IL-22-binding protein exacerbates influenza, bacterial super-infection. Mucosal Immunol 12(5):1231\u20131243. https:\/\/doi.org\/10.1038\/s41385-019-0188-7","journal-title":"Mucosal Immunol"},{"key":"1931_CR2","doi-asserted-by":"publisher","unstructured":"Altai M, Leitao CD, Rinne SS, Vorobyeva A, Atterby C, St\u00e5hl S, Tolmachev V, L\u00f6fblom J, Orlova A (2018) Influence of molecular design on the targeting properties of ABD-fused mono- and Bi-valent Anti-HER3 affibody therapeutic constructs. Cells 7(10). https:\/\/doi.org\/10.3390\/cells7100164","DOI":"10.3390\/cells7100164"},{"issue":"19","key":"1931_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"issue":"20","key":"1931_CR4","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","volume":"582","author":"L Bleicher","year":"2008","unstructured":"Bleicher L, de Moura PR, Watanabe L, Colau D, Dumoutier L, Renauld JC, Polikarpov I (2008) Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism. FEBS Lett 582(20):2985\u20132992. https:\/\/doi.org\/10.1016\/j.febslet.2008.07.046","journal-title":"FEBS Lett"},{"issue":"9997","key":"1931_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. Lancet 386(9997):983\u2013994. https:\/\/doi.org\/10.1016\/s0140-6736(14)61909-7","journal-title":"Lancet"},{"issue":"4","key":"1931_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78(4):1233\u20131261. https:\/\/doi.org\/10.1007\/s00018-020-03656-y","journal-title":"Cell Mol Life Sci"},{"issue":"19","key":"1931_CR7","doi-asserted-by":"publisher","first-page":"e2321836121","DOI":"10.1073\/pnas.2321836121","volume":"121","author":"JL Fachi","year":"2024","unstructured":"Fachi JL, Di Luccia B, Gilfillan S, Chang HW, Song C, Cheng J, Cella M, Vinolo MA, Gordon JI, Colonna M (2024) Deficiency of IL-22-binding protein enhances the ability of the gut microbiota to protect against enteric pathogens. Proc Natl Acad Sci USA 121(19):e2321836121. https:\/\/doi.org\/10.1073\/pnas.2321836121","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1931_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1358\/dot.2010.46.4.1464839","volume":"46","author":"D Farhi","year":"2010","unstructured":"Farhi D (2010) Ustekinumab for the treatment of psoriasis: review of three multicenter clinical trials. Drugs Today (Barc) 46(4):259\u2013264. https:\/\/doi.org\/10.1358\/dot.2010.46.4.1464839","journal-title":"Drugs Today (Barc)"},{"issue":"1","key":"1931_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41401-020-0411-9","volume":"42","author":"YJ Fu","year":"2021","unstructured":"Fu YJ, Xu B, Huang SW, Luo X, Deng XL, Luo S, Liu C, Wang Q, Chen JY, Zhou L (2021) Baicalin prevents LPS-induced activation of TLR4\/NF-\u03baB p65 pathway and inflammation in mice via inhibiting the expression of CD14. Acta Pharmacol Sin 42(1):88\u201396. https:\/\/doi.org\/10.1038\/s41401-020-0411-9","journal-title":"Acta Pharmacol Sin"},{"issue":"51","key":"1931_CR10","doi-asserted-by":"publisher","first-page":"21795","DOI":"10.1073\/pnas.0911472106","volume":"106","author":"H Fujita","year":"2009","unstructured":"Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009) Human Langerhans cells induce distinct IL-22-producing CD4\u2009+\u2009T cells lacking IL-17 production. Proc Natl Acad Sci USA 106(51):21795\u201321800. https:\/\/doi.org\/10.1073\/pnas.0911472106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1931_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3389\/fimmu.2018.01418","volume":"9","author":"T Fukaya","year":"2018","unstructured":"Fukaya T, Fukui T, Uto T, Takagi H, Nasu J, Miyanaga N, Arimura K, Nakamura T, Koseki H, Choijookhuu N, Hishikawa Y, Sato K (2018) Pivotal role of IL-22 binding protein in the epithelial autoregulation of Interleukin-22 signaling in the control of skin inflammation. Front Immunol 9:1418. https:\/\/doi.org\/10.3389\/fimmu.2018.01418","journal-title":"Front Immunol"},{"issue":"1","key":"1931_CR12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M (2020) Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res 53(1):48. https:\/\/doi.org\/10.1186\/s40659-020-00316-0","journal-title":"Biol Res"},{"issue":"9","key":"1931_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-4362.1996.tb03687.x","volume":"35","author":"S Gibbs","year":"1996","unstructured":"Gibbs S (1996) Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol 35(9):633\u2013639. https:\/\/doi.org\/10.1111\/j.1365-4362.1996.tb03687.x","journal-title":"Int J Dermatol"},{"issue":"1","key":"1931_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, Zhang H, Lin W, Lu L, Su J, Chen X (2023) Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther 8(1):437. https:\/\/doi.org\/10.1038\/s41392-023-01655-6","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1931_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10753-013-9715-y","volume":"37","author":"JQ Hao","year":"2014","unstructured":"Hao JQ (2014) Targeting interleukin-22 in psoriasis. Inflammation 37(1):94\u201399. https:\/\/doi.org\/10.1007\/s10753-013-9715-y","journal-title":"Inflammation"},{"issue":"9","key":"1931_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","volume":"16","author":"BC Jones","year":"2008","unstructured":"Jones BC, Logsdon NJ, Walter MR (2008) Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 16(9):1333\u20131344. https:\/\/doi.org\/10.1016\/j.str.2008.06.005","journal-title":"Structure"},{"issue":"8","key":"1931_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/protein\/gzn028","volume":"21","author":"A Jonsson","year":"2008","unstructured":"Jonsson A, Dogan J, Herne N, Abrahms\u00e9n L, Nygren PA (2008) Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel 21(8):515\u2013527. https:\/\/doi.org\/10.1093\/protein\/gzn028","journal-title":"Protein Eng Des Sel"},{"issue":"1","key":"1931_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","volume":"80","author":"SB Kaushik","year":"2019","unstructured":"Kaushik SB, Lebwohl MG (2019) Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol 80(1):27\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.057","journal-title":"J Am Acad Dermatol"},{"key":"1931_CR19","doi-asserted-by":"publisher","unstructured":"Khawar MB, Azam F, Sheikh N, Abdul Mujeeb K (2016) How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis? J Immunol Res 2148129. https:\/\/doi.org\/10.1155\/2016\/2148129","DOI":"10.1155\/2016\/2148129"},{"key":"1931_CR20","doi-asserted-by":"publisher","unstructured":"Lee HJ, Kim M (2023) Challenges and future trends in the treatment of psoriasis. Int J Mol Sci 24(17). https:\/\/doi.org\/10.3390\/ijms241713313","DOI":"10.3390\/ijms241713313"},{"issue":"37","key":"1931_CR21","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC (2002) Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 277(37):33676\u201333682. https:\/\/doi.org\/10.1074\/jbc.M204204200","journal-title":"J Biol Chem"},{"issue":"5","key":"1931_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.intimp.2004.01.010","volume":"4","author":"J Li","year":"2004","unstructured":"Li J, Tomkinson KN, Tan XY, Wu P, Yan G, Spaulding V, Deng B, Annis-Freeman B, Heveron K, Zollner R, De Zutter G, Wright JF, Crawford TK, Liu W, Jacobs KA, Wolfman NM, Ling V, Pittman DD, Veldman GM, Fouser LA (2004) Temporal associations between Interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int Immunopharmacol 4(5):693\u2013708. https:\/\/doi.org\/10.1016\/j.intimp.2004.01.010","journal-title":"Int Immunopharmacol"},{"key":"1931_CR23","doi-asserted-by":"publisher","first-page":"790712","DOI":"10.3389\/fphar.2022.790712","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Liu X, Ge W, Chen C, Huang Y, Jin Z, Zhan M, Duan X, Liu X, Kong Y, Jiang J, Li X, Zeng X, Li F, Xu S, Li M, Chen H (2022) CB2R deficiency exacerbates Imiquimod-Induced psoriasiform dermatitis and itch through the Neuro-Immune pathway. Front Pharmacol 13:790712. https:\/\/doi.org\/10.3389\/fphar.2022.790712","journal-title":"Front Pharmacol"},{"issue":"40","key":"1931_CR24","doi-asserted-by":"publisher","first-page":"18387","DOI":"10.1021\/jacs.2c06532","volume":"144","author":"Y Liu","year":"2022","unstructured":"Liu Y, Bai X, Lyu C, Fang J, Zhang F, Wu WH, Wei W, Zhang WB (2022) Mechano-bioconjugation strategy empowering fusion protein therapeutics with aggregation resistance, prolonged circulation, and enhanced antitumor efficacy. J Am Chem Soc 144(40):18387\u201318396. https:\/\/doi.org\/10.1021\/jacs.2c06532","journal-title":"J Am Chem Soc"},{"issue":"11","key":"1931_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41419-023-06234-9","volume":"14","author":"C Ma","year":"2023","unstructured":"Ma C, Gu C, Lian P, Wazir J, Lu R, Ruan B, Wei L, Li L, Pu W, Peng Z, Wang W, Zong Y, Huang Z, Wang H, Lu Y, Su Z (2023) Sulforaphane alleviates psoriasis by enhancing antioxidant defense through KEAP1-NRF2 pathway activation and attenuating inflammatory signaling. Cell Death Dis 14(11):768. https:\/\/doi.org\/10.1038\/s41419-023-06234-9","journal-title":"Cell Death Dis"},{"issue":"9","key":"1931_CR26","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.4049\/jimmunol.1700021","volume":"198","author":"JC Martin","year":"2017","unstructured":"Martin JC, Wolk K, B\u00e9riou G, Abidi A, Witte-H\u00e4ndel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld JC, Sabat R, Josien R (2017) Limited presence of IL-22 binding protein, a natural IL-22 inhibitor, strengthens psoriatic skin inflammation. J Immunol 198(9):3671\u20133678. https:\/\/doi.org\/10.4049\/jimmunol.1700021","journal-title":"J Immunol"},{"issue":"1","key":"1931_CR27","doi-asserted-by":"publisher","first-page":"1893888","DOI":"10.1080\/19420862.2021.1893888","volume":"13","author":"S Mester","year":"2021","unstructured":"Mester S, Evers M, Meyer S, Nilsen J, Greiff V, Sandlie I, Leusen J, Andersen JT (2021) Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo. MAbs 13(1), 1893888. https:\/\/doi.org\/10.1080\/19420862.2021.1893888","journal-title":"MAbs"},{"key":"1931_CR28","doi-asserted-by":"publisher","first-page":"109388","DOI":"10.1016\/j.cellsig.2019.109388","volume":"63","author":"H M\u00fchl","year":"2019","unstructured":"M\u00fchl H, Bachmann M (2019) IL-18\/IL-18BP and IL-22\/IL-22BP: two interrelated couples with therapeutic potential. Cell Signal 63:109388. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109388","journal-title":"Cell Signal"},{"issue":"5","key":"1931_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.intimp.2004.01.008","volume":"4","author":"ML Nagalakshmi","year":"2004","unstructured":"Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R (2004) Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 4(5):679\u2013691. https:\/\/doi.org\/10.1016\/j.intimp.2004.01.008","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1931_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361(5):496\u2013509. https:\/\/doi.org\/10.1056\/NEJMra0804595","journal-title":"N Engl J Med"},{"issue":"1","key":"1931_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41598-021-04560-6","volume":"12","author":"FY Nikravesh","year":"2022","unstructured":"Nikravesh FY, Shirkhani S, Bayat E, Talebkhan Y, Mirabzadeh E, Sabzalinejad M, Aliabadi HAM, Nematollahi L, Ardakani YH, Sardari S (2022) Extension of human GCSF serum half-life by the fusion of albumin binding domain. Sci Rep 12(1):667. https:\/\/doi.org\/10.1038\/s41598-021-04560-6","journal-title":"Sci Rep"},{"key":"1931_CR32","doi-asserted-by":"publisher","first-page":"212594","DOI":"10.7573\/dic.212594","volume":"8","author":"M Nogueira","year":"2019","unstructured":"Nogueira M, Torres T (2019) Guselkumab for the treatment of psoriasis\u2014evidence to date. Drugs Context 8:212594. https:\/\/doi.org\/10.7573\/dic.212594","journal-title":"Drugs Context"},{"key":"1931_CR33","doi-asserted-by":"publisher","unstructured":"Owen CM, Chalmers RJ, O\u2019Sullivan T, Griffiths CE (2000) Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2Cd001976. https:\/\/doi.org\/10.1002\/14651858.Cd001976","DOI":"10.1002\/14651858.Cd001976"},{"issue":"2","key":"1931_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377\u2013385. https:\/\/doi.org\/10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"issue":"6310","key":"1931_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.aah5903","volume":"354","author":"P Pelczar","year":"2016","unstructured":"Pelczar P, Witkowski M, Perez LG, Kempski J, Hammel AG, Brockmann L, Kleinschmidt D, Wende S, Haueis C, Bedke T, Witkowski M, Krasemann S, Steurer S, Booth CJ, Busch P, K\u00f6nig A, Rauch U, Benten D, Izbicki JR, Huber S (2016) A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease. Science 354(6310):358\u2013362. https:\/\/doi.org\/10.1126\/science.aah5903","journal-title":"Science"},{"key":"1931_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","volume":"7","author":"GK Perera","year":"2012","unstructured":"Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385\u2013422. https:\/\/doi.org\/10.1146\/annurev-pathol-011811-132448","journal-title":"Annu Rev Pathol"},{"key":"1931_CR37","doi-asserted-by":"publisher","unstructured":"Petit RG, Cano A, Ortiz A, Espina M, Prat J, Mu\u00f1oz M, Severino P, Souto EB, Garc\u00eda ML, Pujol M, S\u00e1nchez-L\u00f3pez E (2021) Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci 22(9). https:\/\/doi.org\/10.3390\/ijms22094983","DOI":"10.3390\/ijms22094983"},{"issue":"3","key":"1931_CR38","doi-asserted-by":"publisher","first-page":"adv00032","DOI":"10.2340\/00015555-3386","volume":"100","author":"C Reid","year":"2020","unstructured":"Reid C, Griffiths CEM (2020) Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol 100(3):adv00032. https:\/\/doi.org\/10.2340\/00015555-3386","journal-title":"Acta Derm Venereol"},{"issue":"18","key":"1931_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMra041320","volume":"352","author":"MP Sch\u00f6n","year":"2005","unstructured":"Sch\u00f6n MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352(18):1899\u20131912. https:\/\/doi.org\/10.1056\/NEJMra041320","journal-title":"N Engl J Med"},{"issue":"2","key":"1931_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM (2024) The immunology of Psoriasis-current concepts in pathogenesis. Clin Rev Allergy Immunol 66(2):164\u2013191. https:\/\/doi.org\/10.1007\/s12016-024-08991-7","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1931_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7888\/juoeh.32.317","volume":"32","author":"Y Tokura","year":"2010","unstructured":"Tokura Y, Mori T, Hino R (2010) Psoriasis and other Th17-mediated skin diseases. J Uoeh 32(4):317\u2013328. https:\/\/doi.org\/10.7888\/juoeh.32.317","journal-title":"J Uoeh"},{"key":"1931_CR42","doi-asserted-by":"publisher","unstructured":"Tokuyama M, Mabuchi T (2020) New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci 21(20). https:\/\/doi.org\/10.3390\/ijms21207488","DOI":"10.3390\/ijms21207488"},{"issue":"1","key":"1931_CR43","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1038\/s41598-018-23510-3","volume":"8","author":"S Voglis","year":"2018","unstructured":"Voglis S, Moos S, Kloos L, Wanke F, Zayoud M, Pelczar P, Giannou AD, Pezer S, Albers M, Luessi F, Huber S, Sch\u00e4kel K, Kurschus FC (2018) Regulation of IL-22BP in psoriasis. Sci Rep 8(1):5085. https:\/\/doi.org\/10.1038\/s41598-018-23510-3","journal-title":"Sci Rep"},{"issue":"12","key":"1931_CR44","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1177\/0300060518801463","volume":"46","author":"F Wang","year":"2018","unstructured":"Wang F, Wang J, Zhang Z, Chen S (2018) Tetrandrine inhibits the proliferation and cytokine production induced by IL-22 in HaCaT cells. J Int Med Res 46(12):5210\u20135218. https:\/\/doi.org\/10.1177\/0300060518801463","journal-title":"J Int Med Res"},{"issue":"3","key":"1931_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/sj.gene.6363947","volume":"4","author":"CC Wei","year":"2003","unstructured":"Wei CC, Ho TW, Liang WG, Chen GY, Chang MS (2003) Cloning and characterization of mouse IL-22 binding protein. Genes Immun 4(3):204\u2013211. https:\/\/doi.org\/10.1038\/sj.gene.6363947","journal-title":"Genes Immun"},{"issue":"2","key":"1931_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cpt.1624","volume":"107","author":"H Witjes","year":"2020","unstructured":"Witjes H, Khatri A, Diderichsen PM, Mandema J, Othman AA (2020) Meta-Analyses of clinical efficacy of Risankizumab and adalimumab in chronic plaque psoriasis: supporting evidence of Risankizumab superiority. Clin Pharmacol Ther 107(2):435\u2013442. https:\/\/doi.org\/10.1002\/cpt.1624","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1931_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cytogfr.2006.09.001","volume":"17","author":"K Wolk","year":"2006","unstructured":"Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17(5):367\u2013380. https:\/\/doi.org\/10.1016\/j.cytogfr.2006.09.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"1931_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R (2004) IL-22 increases the innate immunity of tissues. Immunity 21(2):241\u2013254. https:\/\/doi.org\/10.1016\/j.immuni.2004.07.007","journal-title":"Immunity"},{"issue":"5","key":"1931_CR47","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","volume":"87","author":"K Wolk","year":"2009","unstructured":"Wolk K, Haugen HS, Xu W, Witte E, Waggie K, Anderson M, Vom Baur E, Witte K, Warszawska K, Philipp S, Johnson-Leger C, Volk HD, Sterry W, Sabat R (2009) IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 87(5):523\u2013536. https:\/\/doi.org\/10.1007\/s00109-009-0457-0","journal-title":"J Mol Med (Berl)"},{"issue":"40","key":"1931_CR50","doi-asserted-by":"publisher","first-page":"31335","DOI":"10.1074\/jbc.M005304200","volume":"275","author":"MH Xie","year":"2000","unstructured":"Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275(40):31335\u201331339. https:\/\/doi.org\/10.1074\/jbc.M005304200","journal-title":"J Biol Chem"},{"key":"1931_CR51","doi-asserted-by":"publisher","first-page":"766586","DOI":"10.3389\/fimmu.2021.766586","volume":"12","author":"LA Zenewicz","year":"2021","unstructured":"Zenewicz LA (2021) IL-22 binding protein (IL-22BP) in the regulation of IL-22 biology. Front Immunol 12:766586. https:\/\/doi.org\/10.3389\/fimmu.2021.766586","journal-title":"Front Immunol"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-025-01931-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01931-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:00:06Z","timestamp":1755522006000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-025-01931-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1186\/s13568-025-01931-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6841372\/v1","asserted-by":"object"}]},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments conducted in this article were approved by the Laboratory Animal Ethics Committee of Guangdong Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}